Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New insights into the interaction of the immune system with non-small cell lung carcinomas
Paul Hofman
Translational Lung Cancer Research (2020) Vol. 9, Iss. 5, pp. 2199-2213
Open Access | Times Cited: 13

Showing 13 citing articles:

Biomarkers of response to checkpoint inhibitors beyond PD-L1 in lung cancer
Lynette M. Sholl
Modern Pathology (2021) Vol. 35, pp. 66-74
Open Access | Times Cited: 59
Tumour microenvironment changes after osimertinib treatment resistance in non-small cell lung cancer
Ruoshuang Han, Haoyue Guo, Jinpeng Shi, et al.
European Journal of Cancer (2023) Vol. 189, pp. 112919-112919
Open Access | Times Cited: 18
The role of macrophages in non-small cell lung cancer and advancements in 3D co-cultures
Katarína Balážová, Hans Clevers, Antonella F. M. Dost
eLife (2023) Vol. 12
Open Access | Times Cited: 14
ALKBH1-8 and FTO: Potential Therapeutic Targets and Prognostic Biomarkers in Lung Adenocarcinoma Pathogenesis
Geting Wu, Yuanliang Yan, Yuan Cai, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 24
The Impact of NK Cell-Based Therapeutics for the Treatment of Lung Cancer for Biologics: Targets and Therapy
Gerhard Hamilton, Adelina Plangger
Biologics (2021) Vol. Volume 15, pp. 265-277
Open Access | Times Cited: 20
To inhibit or to boost the ATP/P2RX7 pathway to fight cancer—that is the question
Séréna Janho dit Hreich, Jonathan Benzaquen, Paul Hofman, et al.
Purinergic Signalling (2021) Vol. 17, Iss. 4, pp. 619-631
Open Access | Times Cited: 15
Artificial neural network–based diagnostic models for lung cancer combining conventional indicators with tumor markers
Yanan Luo, Hui Yuan, Pei Qin, et al.
Experimental Biology and Medicine (2023) Vol. 248, Iss. 10, pp. 829-838
Open Access | Times Cited: 5
Prognostic Value of Dual-Time-Point [18F]FDG PET/CT for Predicting Distant Metastasis after Treatment in Patients with Non-Small Cell Lung Cancer
Sang Mi Lee, Jeong Won Lee, Ji-Hyun Lee, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 4, pp. 592-592
Open Access | Times Cited: 4
Macrophages and tertiary lymphoid structures as indicators of prognosis and therapeutic response in cancer patients
Li Niu, Ting Chen, Aodan Yang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189125-189125
Closed Access
The role of immunotherapy in patients with lung cancer and brain metastases: a narrative review of the literature
Eleni Eleftheriadou, Maria Saroglou, Nikolaos Syrigos, et al.
Monaldi Archives for Chest Disease (2024)
Open Access
The interaction of p53 and DNA repair gene mutations and their impact on tumor mutation burden and immune response in human malignancies.
Xuemin Xue, Dong Lin, Edwina Burke, et al.
PubMed (2022) Vol. 12, Iss. 4, pp. 1866-1883
Closed Access | Times Cited: 2
Prognostic Biomarkers after Radiotherapy for Nonsmall Cell Lung Cancer Based on Bioinformatics Analysis
Kejun Li, Shuang Wang, Na Li, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 2
Single-cell sequencing reveals lung cell fate evolution initiated by smoking to explore gene predictions of correlative diseases
Lei Xu, Taiying Lu
Toxicology Mechanisms and Methods (2023) Vol. 34, Iss. 4, pp. 369-384
Closed Access
Page 1

Scroll to top